ROCHE-AVF2107g

Study Sponsor : Roche

Study Title

A phase III, multicenter, randomized, active-controlled clinical trial to evaluate the efficacy and safety of rhumab vegf (bevacizumab) in combination with standard chemotherapy in subjects with metastatic colorectal cancer

Medicine or Vaccine (generic name)

bevacizumab

Sponsor Identification Number

AVF2107g

Trial Registry Identification Number(#'s)

NCT00109070

Medical Condition

metastatic colorectal cancer

Phase

Phase 3

Link to study details on the Roche Clinical Study Register

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/ct2/show/NCT00109070

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

January 2014